Table 2. Effect of different doses of berberine on urinary uric acid level (mg/dl) of hyperuricemic rats (n = 6) on day 0, 1, 3 and 7.
Urinary Uric Acid (mg/dl) | |||||||
Groups | Day 0 Mean ± SD | Day 1 Mean ± SD | Day 3 Mean ± SD | Day 7 Mean ± SD | Repeated measure ANOVA p-value | ||
Normal control (A) | 7.4 ± 2.3 | 7.3 ± 2.3 | 7.0 ± 1.9 | 7.2 ± 1.9 | 0.403 | ||
Disease control (B) | 7.6 ± 2.2 | 10.9 ± 3.2 | 12.6 ± 3.0 | 14.6 ± 2.9 | 0.067 | ||
Standard drug Allopurinol (C) | 9.4 ± 1.2 | 11.7 ± 3.5 | 9.6 ± 3.5 | 7.8 ± 3.3 | 0.182 | ||
Low dose berberine (D) | 8.6 ± 3.8 | 6.9 ± 4.5 | 20.4 ± 12.7 | 48.5 ± 10.2 | 0.028 | ||
Medium dose berberine (E) | 10.1 ± 5.5 | 6.5 ± 4.7 | 12.3 ± 6.2 | 24.7 ± 10.9 | 0.025 | ||
High dose berberine (F) | 7.2 ± 2.9 | 4.8 ± 1.9 | 6.8 ± 2.1 | 17.1 ± 7.3 | 0.052 | ||
p-value (ANOVA) | 0.575 | 0.01 | 0.007 | <0.001 |